Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions ; day:10 ; month:2 ; year:2017 ; pages:1-7
Clinical drug investigation ; (10.2.2017), 1-7
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Creator
-
Hövelmann, Ulrike
- Contributor
-
Heise, Tim
Nosek, Leszek
Sassenfeld, Bettina
Thomsen, Karen Margrete Due
Haahr, Hanne
SpringerLink (Online service)
- DOI
-
10.1007/s40261-017-0499-y
- URN
-
urn:nbn:de:1111-2017030516346
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hövelmann, Ulrike
- Heise, Tim
- Nosek, Leszek
- Sassenfeld, Bettina
- Thomsen, Karen Margrete Due
- Haahr, Hanne
- SpringerLink (Online service)
Other Objects (12)
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Bioavailability of IgG Administered by the Subcutaneous Route
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Absorption of Different Salts of Heparin Following Subcutaneous Injection
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Bioavailability of IgG Administered by the Subcutaneous Route
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Absorption of Different Salts of Heparin Following Subcutaneous Injection
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Bioavailability of IgG Administered by the Subcutaneous Route
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Absorption of Different Salts of Heparin Following Subcutaneous Injection
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach